NEW YORK (GenomeWeb News) – BioForce Nanosciences said today that it has closed a $300,000 convertible debt financing from its largest shareholder.
 
The Ames, Iowa-based company said the investment involved issuing $300,000 of convertible secured promissory notes, which are convertible into shares of the firm’s common stock at $.30 per share, and the issuance of 900,000 warrants for the company’s common stock at $.30 per share.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.